Research Focus

Medicine; Associate Attending

Recent additions – View all

1. Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma – A registry analysis from the DRST

   Journal Article

   Merz, M.; Gagelmann, N.; Smaili, S.; Flossdorf, S.; Sauer, S.; Scheid, C.; von Tresckow, B.; Wulf, G.; Weisel, K.; Blau, I. W.; more...
   Blood (2025)

   Fulltext@MSK | Save
2. Emerging T-cell lymphomas after CAR T-cell therapy

   Editorial

   Braun, T.; Kuschel, F.; Reiche, K.; Merz, M.; Herling, M.
   Leukemia (2025)

   Fulltext@MSK | Save
3. Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma

   Journal Article

   Born, P.; Fandrei, D.; Wang, S. Y.; Perez-Fernandez, C.; Fischer, L.; Ussmann, J.; Bach, E.; Hoffmann, S.; Metzeler, K. H.; Herling, M.; more...
   HemaSphere (2025)

   Fulltext@MSK | Save